These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33936032)

  • 1. Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective.
    Boniface K; Passeron T; Seneschal J; Tulic MK
    Front Immunol; 2021; 12():613056. PubMed ID: 33936032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune mechanisms in vitiligo: danger from within.
    Richmond JM; Frisoli ML; Harris JE
    Curr Opin Immunol; 2013 Dec; 25(6):676-82. PubMed ID: 24238922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the PD-1/PD-L1 Axis in Human Vitiligo.
    Willemsen M; Melief CJM; Bekkenk MW; Luiten RM
    Front Immunol; 2020; 11():579022. PubMed ID: 33240267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors.
    Faraj S; Kemp EH; Gawkrodger DJ
    Clin Exp Immunol; 2022 Jan; 207(1):27-43. PubMed ID: 35020865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunity as an aetiological factor in vitiligo.
    Rezaei N; Gavalas NG; Weetman AP; Kemp EH
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.
    Wang Y; Li S; Li C
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):299-323. PubMed ID: 34283349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.
    Jadeja SD; Mayatra JM; Vaishnav J; Shukla N; Begum R
    Front Immunol; 2020; 11():624566. PubMed ID: 33613564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding mechanisms of autoimmunity through translational research in vitiligo.
    Strassner JP; Harris JE
    Curr Opin Immunol; 2016 Dec; 43():81-88. PubMed ID: 27764715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo: interplay between oxidative stress and immune system.
    Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
    Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKG2D Defines a Subset of Skin Effector Memory CD8 T Cells with Proinflammatory Functions in Vitiligo.
    Jacquemin C; Martins C; Lucchese F; Thiolat D; Taieb A; Seneschal J; Boniface K
    J Invest Dermatol; 2020 Jun; 140(6):1143-1153.e5. PubMed ID: 31877315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trained immunity in the pathogenesis of vitiligo.
    Post NF; Ginski G; Peters R; Van Uden NOP; Bekkenk MW; Wolkerstorfer A; Netea MG; Luiten RM
    Pigment Cell Melanoma Res; 2023 Sep; 36(5):348-354. PubMed ID: 37293969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The haptenation theory of vitiligo and melanoma rejection: a close-up.
    Westerhof W; Manini P; Napolitano A; d'Ischia M
    Exp Dermatol; 2011 Feb; 20(2):92-6. PubMed ID: 21255087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection.
    Xie B; Zhu Y; Shen Y; Xu W; Song X
    Expert Opin Ther Targets; 2023 Mar; 27(3):189-206. PubMed ID: 36947026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of immune cell network in autoimmune skin disorders: An update on pemphigus, vitiligo and psoriasis.
    Das D; Akhtar S; Kurra S; Gupta S; Sharma A
    Cytokine Growth Factor Rev; 2019 Feb; 45():35-44. PubMed ID: 30773437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Damage-associated molecular patterns in vitiligo: igniter fuse from oxidative stress to melanocyte loss.
    Wang J; Pan Y; Wei G; Mao H; Liu R; He Y
    Redox Rep; 2022 Dec; 27(1):193-199. PubMed ID: 36154894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.
    Harris JE
    Immunol Rev; 2016 Jan; 269(1):11-25. PubMed ID: 26683142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate lymphoid cells in autoimmunity and chronic inflammatory diseases.
    Xiong T; Turner JE
    Semin Immunopathol; 2018 Jul; 40(4):393-406. PubMed ID: 29568972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.